Nanto City and GigaStream Toyama Conclude Agreement for the Development of Japan's Largest Data Center Cluster (3.1GW) including the acquisition of Phase 1 Land to Support 400MW
— Realizing Japan's "Third Major Data Center Cluster," Following Tokyo and Osaka — NANTO, Japan, Dec. 19, 2025 /PRNewswire/ -- Nanto City (Mayor Mikio Tanaka) and GigaStream Toyama K.K. (1-chome Honmachi, Nanto City; Representative Director: Daniel...
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature
SAN FRANCISCO and SUZHOU, China, Dec. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
FUTURE FUND OMAN COMMITS $1.2 BILLION AS $5.2 BILLION INVESTMENT PROGRAM ACCELERATES ECONOMIC DIVERSIFICATION
MUSCAT, Oman, Dec. 18, 2025 /PRNewswire/ -- Future Fund Oman announced record activity in 2025, approving 141 projects this year and lifting total commitments to $1.2 billion as the fund accelerates Oman's economic diversification agenda....
Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
SHANGHAI and HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Paranovus Entertainment Technology Limited Announces 1-For-100 Reverse Share Split
NEW YORK, Dec. 16, 2025 /PRNewswire/ -- Paranovus Entertainment Technology Limited (NASDAQ: PAVS), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.01 per share (the "Class A Ordinary...
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab
HONG KONG, Dec. 12, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a...
MMTEC, Inc. Announces Receipt of Nasdaq Decision Regarding Minimum Bid Price Deficiency
HONG KONG, Dec. 11, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on December 9, 2025, the Company...
Qudian Inc. Announces Name and Ticker Change
XIAMEN, China, Dec. 11, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced the change of its name to "High Templar Tech Limited" and its ticker symbol to...
CNFINANCE ANNOUNCES THE RESULTS OF ITS EXTRAORDINARY GENERAL MEETING
GUANGZHOU, China, Dec. 10, 2025 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced the results of its extraordinary general meeting of...
Autozi Internet Technology (Global) Ltd. Announces 50 for 1 Share Consolidation
BEIJING, Dec. 10, 2025 /PRNewswire/ -- Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) (the "Company" or "Autozi"), one of the leading and fast-growing lifecycle automotive service providers in China, today announced that the Company's board...